MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 1281 to 1300 of 1,960 approvalsPage 65 of 98

Ryzodeg

Authorisation: Jan 21, 2013

Tresiba

Authorisation: Jan 20, 2013

Amyvid

Authorisation: Jan 14, 2013

Bexsero

Authorisation: Jan 13, 2013

Bexsero

Authorisation: Jan 13, 2013

Imatinib Teva

Authorisation: Jan 7, 2013

Betmiga

Authorisation: Dec 20, 2012

Betmiga

Authorisation: Dec 20, 2012

NexoBrid

Authorisation: Dec 18, 2012

Memantine Merz

Authorisation: Nov 22, 2012

Eylea

Authorisation: Nov 21, 2012

Forxiga

Authorisation: Nov 11, 2012

Adcetris

Authorisation: Oct 25, 2012

Xalkori

Authorisation: Oct 23, 2012

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.